ExpreS²ion Biotechnologies and AdaptVac will be presenting at the free webinar on March 14 at 5PM CET / 4PM GMT / 12PM EDT / 9AM PDT, hosted by the leading science journal published by Elsevier, Vaccine. The webinar is titled “Developing a HER2-VLP vaccine for treatment of HER2-positive cancer; optimizing the potential by combining Drosophila S2 insect cells manufacturing with a novel VLP-display technology.” The speakers are Dr. Wian de Jongh, CSO, ExpreS²ion Biotechnologies, and Dr. Adam F. Sander, Associate Professor, Copenhagen University.

Please join by registering at the following link: http://view6.workcast.net/register?cpak=9710303814129192